| Model 1 | Model 2 | ||||||
---|---|---|---|---|---|---|---|---|
Control group (n = 1048) | T2DM(HTN−) (n = 277) | T2DM(HTN +) (n = 823) | T2DM(HTN−) (n = 277) | T2DM(HTN +) (n = 823) | ||||
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |||
 | Reference |  |  |  |  | Reference |  |  |
Any calcified plaque | – | 0.170 | 1.669 (1.351–2.062) |  < 0.001 | – | 0.074 | ||
Any partially calcified plaque | 1.513 (1.133–2.022) | 0.005 | 2.323 (1.870–2.887) |  < 0.001 | 1.561 (1.144–2.130) | 0.005 | ||
Any noncalcified plaque | – | 0.084 | 1.278 (1.033–1.580) | 0.024 | – | 0.604 | ||
Any obstructive CAD | 1.629 (1.222–2.170) | 0.001 | 1.992 (1.616–2.455) |  < 0.001 | – | 0.161 | ||
Multivessel disease | 1.892 (1.393–2.568) |  < 0.001 | 3.372 (2.619–4.342) |  < 0.001 | 1.867 (1.337–2.608) |  < 0.001 | ||
SIS > 3 | 2.233 (1.684–2.961) |  < 0.001 | 3.769 (3.046–4.663) |  < 0.001 | 1.647 (1.231–2.204) | 0.001 | ||
SSS > 5 | 2.057 (1.554–2.722) |  < 0.001 | 3.580 (2.902–4.417) |  < 0.001 | 1.625 (1.221–2.162) | 0.001 |